Exome-Based Trio Analysis for Diagnosis of the Cause of Congenital Severe Hemolytic Anemia in a Child

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Exome-Based Trio Analysis for Diagnosis of the Cause of Congenital Severe Hemolytic Anemia in a Child. / Rieneck, Klaus; Lausen, Birgitte; Clausen, Frederik Banch; Jønson, Lars; Hansen, Anne Todsen; Dziegiel, Morten Hanefeld.

In: Transfusion Medicine and Hemotherapy, Vol. 49, No. 5, 2022, p. 320-325.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Rieneck, K, Lausen, B, Clausen, FB, Jønson, L, Hansen, AT & Dziegiel, MH 2022, 'Exome-Based Trio Analysis for Diagnosis of the Cause of Congenital Severe Hemolytic Anemia in a Child', Transfusion Medicine and Hemotherapy, vol. 49, no. 5, pp. 320-325. https://doi.org/10.1159/000523706

APA

Rieneck, K., Lausen, B., Clausen, F. B., Jønson, L., Hansen, A. T., & Dziegiel, M. H. (2022). Exome-Based Trio Analysis for Diagnosis of the Cause of Congenital Severe Hemolytic Anemia in a Child. Transfusion Medicine and Hemotherapy, 49(5), 320-325. https://doi.org/10.1159/000523706

Vancouver

Rieneck K, Lausen B, Clausen FB, Jønson L, Hansen AT, Dziegiel MH. Exome-Based Trio Analysis for Diagnosis of the Cause of Congenital Severe Hemolytic Anemia in a Child. Transfusion Medicine and Hemotherapy. 2022;49(5):320-325. https://doi.org/10.1159/000523706

Author

Rieneck, Klaus ; Lausen, Birgitte ; Clausen, Frederik Banch ; Jønson, Lars ; Hansen, Anne Todsen ; Dziegiel, Morten Hanefeld. / Exome-Based Trio Analysis for Diagnosis of the Cause of Congenital Severe Hemolytic Anemia in a Child. In: Transfusion Medicine and Hemotherapy. 2022 ; Vol. 49, No. 5. pp. 320-325.

Bibtex

@article{ec59b12e66f64895aa2090d77a06a799,
title = "Exome-Based Trio Analysis for Diagnosis of the Cause of Congenital Severe Hemolytic Anemia in a Child",
abstract = "Inborn hemolytic anemia requiring frequent blood transfusions can be a life-threatening disease. Treatment, besides blood transfusion, includes iron chelation for prevention of iron accumulation due to frequent blood transfusions. We present the results of a clinical investigation where the proband was diagnosed with severe hemolytic anemia of unknown origin soon after birth. Transfusion was required every 4-6 weeks. After whole exome sequencing of the proband and his parents as well as a healthy sibling, we established that the proband had a compound heterozygous state carrying two rare variants in the erythrocytic spectrin gene, SPTA1. The maternal allele was a stop mutation (rs755630903) and the paternal allele was a missense mutation (rs375506528). The healthy sibling had the paternal variant but not the maternal variant. These rare variants of SPTA1 most likely account for the hemolytic anemia. A severely reduced osmotic resistance in the erythrocytes from the proband was demonstrated. Splenectomy considerably improved the hemolytic anemia and obviated the need for blood transfusion despite the severe clinical presentation.",
keywords = "Hemolytic anemia, Hereditary, Spherocytosis, Variant detection, Whole exome sequencing",
author = "Klaus Rieneck and Birgitte Lausen and Clausen, {Frederik Banch} and Lars J{\o}nson and Hansen, {Anne Todsen} and Dziegiel, {Morten Hanefeld}",
note = "Publisher Copyright: {\textcopyright} 2022 The Author(s). Published by S. Karger AG, Basel.",
year = "2022",
doi = "10.1159/000523706",
language = "English",
volume = "49",
pages = "320--325",
journal = "Transfusion Medicine and Hemotherapy",
issn = "1660-3796",
publisher = "S Karger AG",
number = "5",

}

RIS

TY - JOUR

T1 - Exome-Based Trio Analysis for Diagnosis of the Cause of Congenital Severe Hemolytic Anemia in a Child

AU - Rieneck, Klaus

AU - Lausen, Birgitte

AU - Clausen, Frederik Banch

AU - Jønson, Lars

AU - Hansen, Anne Todsen

AU - Dziegiel, Morten Hanefeld

N1 - Publisher Copyright: © 2022 The Author(s). Published by S. Karger AG, Basel.

PY - 2022

Y1 - 2022

N2 - Inborn hemolytic anemia requiring frequent blood transfusions can be a life-threatening disease. Treatment, besides blood transfusion, includes iron chelation for prevention of iron accumulation due to frequent blood transfusions. We present the results of a clinical investigation where the proband was diagnosed with severe hemolytic anemia of unknown origin soon after birth. Transfusion was required every 4-6 weeks. After whole exome sequencing of the proband and his parents as well as a healthy sibling, we established that the proband had a compound heterozygous state carrying two rare variants in the erythrocytic spectrin gene, SPTA1. The maternal allele was a stop mutation (rs755630903) and the paternal allele was a missense mutation (rs375506528). The healthy sibling had the paternal variant but not the maternal variant. These rare variants of SPTA1 most likely account for the hemolytic anemia. A severely reduced osmotic resistance in the erythrocytes from the proband was demonstrated. Splenectomy considerably improved the hemolytic anemia and obviated the need for blood transfusion despite the severe clinical presentation.

AB - Inborn hemolytic anemia requiring frequent blood transfusions can be a life-threatening disease. Treatment, besides blood transfusion, includes iron chelation for prevention of iron accumulation due to frequent blood transfusions. We present the results of a clinical investigation where the proband was diagnosed with severe hemolytic anemia of unknown origin soon after birth. Transfusion was required every 4-6 weeks. After whole exome sequencing of the proband and his parents as well as a healthy sibling, we established that the proband had a compound heterozygous state carrying two rare variants in the erythrocytic spectrin gene, SPTA1. The maternal allele was a stop mutation (rs755630903) and the paternal allele was a missense mutation (rs375506528). The healthy sibling had the paternal variant but not the maternal variant. These rare variants of SPTA1 most likely account for the hemolytic anemia. A severely reduced osmotic resistance in the erythrocytes from the proband was demonstrated. Splenectomy considerably improved the hemolytic anemia and obviated the need for blood transfusion despite the severe clinical presentation.

KW - Hemolytic anemia

KW - Hereditary

KW - Spherocytosis

KW - Variant detection

KW - Whole exome sequencing

U2 - 10.1159/000523706

DO - 10.1159/000523706

M3 - Journal article

AN - SCOPUS:85128569583

VL - 49

SP - 320

EP - 325

JO - Transfusion Medicine and Hemotherapy

JF - Transfusion Medicine and Hemotherapy

SN - 1660-3796

IS - 5

ER -

ID: 314960660